Publication | Open Access

HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain

Molecular PharmacologyPain SyndromePain TherapyPain MedicineMedicineNeuropathic PainMouse ModelsNeuropharmacologyMolecular PainPharmacotherapyNeurosciencePain MechanismPharmacologyDrug DiscoveryPain Research